Nanotechnology for next-generation cancer immunotherapy: State of the art and future perspectives
Author:
Funder
Ministry of Education
Ministry of Science and Technology, Taiwan
National Health Research Institutes
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference86 articles.
1. Immune checkpoint inhibitors: recent progress and potential biomarkers;Darvin;Exp. Mol. Med.,2018
2. Cytokines in clinical cancer immunotherapy;Berraondo;Br. J. Cancer,2019
3. Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors;Ye;Adv. Drug Deliv. Rev.,2021
4. Challenges towards the realization of individualized cancer vaccines;Tureci;Nat. Biomed. Eng.,2018
5. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges;Depil;Nat. Rev. Drug Discov.,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-stromal nanotherapeutics for hepatocellular carcinoma;Journal of Controlled Release;2024-03
2. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion;International Journal of Molecular Sciences;2024-01-23
3. LncRNA-edited biomimetic nanovaccines combined with anti-TIM-3 for augmented immune checkpoint blockade immunotherapy;Journal of Controlled Release;2023-09
4. A new approach to overcoming resistance to immunotherapy: nanotechnology;Frontiers in Oncology;2023-08-10
5. Use of multi-walled carbon nanotubes (MWCNTs) stabilized in Arabic gum colloidal solution to induce genotoxicity and apoptosis of human breast and lung cancer cell lines;Frontiers in Materials;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3